Ellenbarrie Industrial Gases Limited is a premier Indian-owned manufacturer and supplier of industrial and medical gases with a legacy spanning over **50 years**. The company holds a dominant market position in the Eastern and Southern regions of India, specifically leading by installed capacity in **West Bengal, Andhra Pradesh, and Telangana**. As of **March 2025**, the company serves a diversified portfolio of **1,829 customers** across critical sectors including steel, pharmaceuticals, healthcare, defense, and emerging high-tech manufacturing. --- ### **Core Business Verticals & Revenue Streams** The company operates through two primary reporting segments, utilizing a multi-modal distribution strategy to ensure high customer retention and operational resilience. * **Gases, Related Products & Services (~88% of Revenue):** The core growth engine, delivering robust **EBITDA margins of ~38%**. This segment focuses on the production of Oxygen, Nitrogen, and Argon. * **Project Engineering:** An in-house division providing turnkey design, engineering, and commissioning of Air Separation Units (**ASUs**) and Medical Gas Pipeline Systems (**MGPS**). This vertical reduces reliance on external consultants, lowers internal Capex for expansions, and provides a secondary revenue stream through third-party projects. #### **Supply & Distribution Formats** | Format | Description | Contractual Nature | | :--- | :--- | :--- | | **On-site Plants** | Facilities built within or adjacent to customer premises (e.g., **Tata Steel Metaliks**). | Long-term **"take-or-pay"** contracts (**5 years** for private; **1-2 years** for govt). | | **Bulk/Merchant** | Independent plants supplying liquid gases via cryogenic tankers. | Serves customers within a **500-km radius** of plants like **Uluberia** and **Kurnool**. | | **Packaged/Cylinders** | Distribution of compressed gases via a network of **39,560+ cylinders**. | Targeted at smaller-scale industrial and medical users. | --- ### **Product Dynamics & High-Margin Specialization** While the company produces a wide array of gases, it is increasingly pivoting toward high-purity and specialty products that command superior margins. * **Core Air Gases:** Revenue is primarily driven by **Oxygen (~40% of market)** and **Nitrogen**. * **Argon Advantage:** Argon is a high-value byproduct essential for the solar ingot and steel industries. It currently represents **~13%** of revenue, with a strategic target to increase this to **15%+**. * **Solar & Semiconductor Pivot:** The company is establishing a **Western Region facility** to integrate high-purity plants with specialized warehouses. * **UHP Gases:** Manufacturing **Ultra-High Purity (99.9999%)** Nitrogen and Oxygen for solar cell manufacturing with margins **significantly higher** than the company average. * **Trading & Value-Add:** Importing specialty gases (Silane, UHP Ammonia) from China and "breaking bulk" into smaller packages for localized distribution, targeting **15% to 20% margins**. --- ### **Operational Infrastructure & Capacity Roadmap** The company is aggressively expanding its footprint to transition from a regional leader to a **Pan-India** player. | Metric / Facility | Status / Capacity Details | | :--- | :--- | | **Total Installed Capacity (FY25)** | **3,870 TPD** (Total) / **1,370 TPD** (Owned & Operated) | | **Target Capacity (End FY26)** | **1,910 TPD** (Owned & Operated) | | **Target Capacity (End FY27)** | **2,130 TPD** (Owned & Operated) | | **Uluberia-II (West Bengal)** | **220 TPD** (Commenced Jan 2026; **₹100+ Cr** revenue potential) | | **Kurnool (Andhra Pradesh)** | **600 TPD** (Currently at **87%** utilization) | | **East India On-site Plant** | **320 TPD** (Expected **Q1 FY27**) | | **North India Merchant Plant** | **220 TPD** (Expected **H2 FY27**) | --- ### **Financial Performance & Capital Structure** Following its **June 2025 IPO**, which raised **₹852.53 crore** (including a **₹400 crore** fresh issue), the company maintains a fortress balance sheet to fund its capital-intensive growth. #### **Key Financial Metrics** | Metric | FY 2024 | FY 2025 | | :--- | :--- | :--- | | **Revenue from Operations** | ₹269.38 Cr | **₹312.48 Cr** | | **EBITDA Margin** | 22.83% | **35.12%** | | **Profit After Tax (PAT)** | ₹45.29 Cr | **₹83.29 Cr** | | **Return on Equity (RoE)** | 11.05% | **16.88%** | | **Net Cash Position** | - | **₹355 Cr** (as of Feb 2026) | * **Growth Guidance:** Management targets a **20-25% Revenue CAGR** in the core gases business over the next **4-5 years**. * **Margin Outlook:** Long-term **EBITDA margin target of ~40%**, supported by power-efficient new plants and higher-margin onsite capacities. * **Capital Allocation:** Disciplined Capex of **₹250 crore (FY26)** and **₹200 crore (FY27)**, targeting an **ROCE >15%**. --- ### **Strategic Growth Pillars** 1. **Energy Efficiency:** Power is the single largest cost. The company has signed a **25-year PPA** for a **6 MW** wind-solar hybrid plant and took a **26% equity stake** in **Pattikonda Renewables** to lower long-term energy tariffs. 2. **Inorganic Consolidation:** Actively acquiring smaller regional players, evidenced by the **₹5.4 crore** acquisition of **Truair Industrial Gases** in 2025. 3. **Digital Integration:** Utilizing digital telemetry for remote inventory monitoring at customer sites, contributing to an **85% repeat business rate**. 4. **Market Positioning:** Currently the **4th or 5th** largest player in India with a **4-5%** share of a **₹15,000 crore** market, competing directly with MNCs like Linde India and Inox Air Products. --- ### **Risk Assessment & Mitigation** * **Project Execution:** Greenfield projects are subject to minor delays (e.g., the East India plant shift from Q4 FY26 to Q1 FY27). Management mitigates this by factoring in a **1.5 to 2-year** ramp-up period for all new facilities. * **Sectoral Cyclicality:** Exposure to the steel sector can impact **Argon** pricing. The company is mitigating this by diversifying into **Pharmaceuticals, Semiconductors, and Space Research**. * **Financial Oversight:** A formal **Financial Risk Committee** manages credit risk (individual limits by days/amount) and liquidity risk to ensure funding for lease liabilities and trade payables. * **Legal Contingencies:** The company is currently contesting a **₹3.5 crore** supplier claim but expects a favorable outcome with no financial provision deemed necessary.